You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,560,076


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,560,076 protect, and when does it expire?

Patent 7,560,076 protects GENOSYL and is included in one NDA.

This patent has nine patent family members in five countries.

Summary for Patent: 7,560,076
Title:Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.
Inventor(s): Rounbehler; David R. (Las Cruces, NM), Fine; David H. (Cocoa Beach, FL)
Assignee: GENO LLC (Lincoln, MA)
Application Number:11/206,305
Patent Claim Types:
see list of patent claims
Formulation; Delivery; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,560,076

Introduction

When analyzing a patent, it is crucial to delve into its scope, claims, and the broader patent landscape to understand its significance, validity, and potential impact. This article will provide a detailed analysis of the United States Patent 7,560,076, focusing on its claims, scope, and the surrounding patent landscape.

Patent Overview

United States Patent 7,560,076, like any other patent, is a grant of rights for an invention, issued by the U.S. Patent and Trademark Office (USPTO)[2].

Claims Analysis

Claim Structure

Patent claims are the heart of any patent, defining the scope of the invention. The claims of U.S. Patent 7,560,076 would typically include independent and dependent claims.

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are crucial in determining the patent's scope[3].
  • Dependent Claims: These claims refer back to and further limit the independent claims, often adding specific details or features.

Claim Language and Scope

The language used in the claims is critical. Independent claim length and count can be metrics to measure patent scope. Narrower claims, as indicated by shorter lengths and fewer counts, are often associated with a higher probability of grant and a shorter examination process[3].

Patent Scope

Definition and Importance

Patent scope refers to the breadth of protection granted by the patent. It is a key aspect in debates over patent quality, as overly broad patents can lead to increased licensing and litigation costs, potentially diminishing innovation incentives[3].

Metrics for Measuring Scope

  • Independent Claim Length: Shorter independent claims generally indicate narrower scope.
  • Independent Claim Count: Fewer independent claims suggest a more focused invention.
  • Forward Citations and Patent Maintenance Payments: These can also serve as indicators of patent scope and quality[3].

Patent Landscape

Related Patents and Family Members

Understanding the patent family and related patents is essential. For example, if U.S. Patent 7,560,076 is part of a larger patent family, it may have continuations-in-part, continuations, or divisional applications, each with its own claims and scope. This was evident in the case of Cellect LLC, where multiple patents were interrelated and claimed priority from a single application[1].

Global Dossier and International Search

The Global Dossier service provided by the USPTO allows users to see the patent family for a specific application, including related applications filed at participating IP Offices. This can help in understanding the global patent landscape and potential overlaps or conflicts[4].

Obviousness-Type Double Patenting (ODP)

ODP is a critical consideration, especially if the patent in question is part of a larger family. ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of Patent Term Adjustment (PTA)[1].

Examination Process and Public Search Tools

The examination process can significantly narrow the scope of patent claims. Tools like the Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) are invaluable for conducting thorough searches and understanding the prior art landscape[4].

Public Search Facility and Official Gazette

The USPTO Public Search Facility and the Electronic Official Gazette provide access to patent and trademark information, allowing users to browse through issued patents and identify potential conflicts or overlaps[4].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application, facilitating a more comprehensive understanding of the patent landscape[4].

International Patent Offices

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), is essential for a global perspective on the patent landscape[4].

Patent Assignment and Examination Data

Tools like the Patent Assignment Search and the Patent Examination Data System (PEDS) provide insights into ownership changes and examination data, which can be crucial in assessing the patent's validity and enforcement potential[4].

Illustrative Statistics and Expert Insights

  • Narrower Claims: Studies have shown that narrower claims are associated with a higher probability of grant and shorter examination processes. For instance, a large-scale analysis found that the examination process tends to narrow the scope of patent claims in terms of both claim length and claim count[3].
  • Expert Insights: According to patent experts, the clarity and specificity of claims are critical in determining the patent's scope and validity. "The purported decrease in patent quality over the past decade or two has supposedly led to granting patents of increased breadth (or ‘overly broad’ patents), decreased clarity, and questionable validity," highlights a study on patent scope[3].

Key Takeaways

  • Claims Analysis: Independent and dependent claims define the patent's scope.
  • Patent Scope Metrics: Independent claim length and count are key metrics.
  • Patent Landscape: Understanding related patents and global filings is crucial.
  • ODP Considerations: Prevents securing a second, later-expiring patent for the same invention.
  • Public Search Tools: Essential for thorough searches and understanding prior art.
  • International Search: Necessary for a comprehensive global perspective.

FAQs

What is the importance of independent claims in a patent?

Independent claims define the invention without reference to other claims and are crucial in determining the patent's scope.

How does the examination process affect patent claims?

The examination process tends to narrow the scope of patent claims in terms of both claim length and claim count, making the claims more specific and focused.

What is Obviousness-Type Double Patenting (ODP)?

ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of PTA.

What tools are available for conducting a thorough patent search?

Tools include the Patent Public Search, Global Dossier, Patent and Trademark Resource Centers (PTRCs), and the Electronic Official Gazette.

Why is it important to search international patent databases?

Searching international patent databases provides a global perspective on the patent landscape, helping to identify potential conflicts or overlaps.

Cited Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1]
  2. U.S. Patent and Trademark Office (USPTO) - USA.gov[2]
  3. Patent Claims and Patent Scope - SSRN[3]
  4. Search for patents - USPTO - USPTO[4]

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,560,076

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Vero Biotech Inc GENOSYL nitric oxide GAS;INHALATION 202860-001 Dec 20, 2019 RX Yes Yes 7,560,076 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,560,076

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2005277397 ⤷  Subscribe
Canada 2576957 ⤷  Subscribe
European Patent Office 1789119 ⤷  Subscribe
European Patent Office 2724742 ⤷  Subscribe
Japan 2008510675 ⤷  Subscribe
Japan 2012179365 ⤷  Subscribe
Japan 5421530 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.